ask="35.00"
ask_size="1100"
average_daily_volume="349397"
bid="29.00"
bid_size="200"
book_value="3.58"
change="-0.01"
change_from_200_day_moving_average="4.76"
change_from_50_day_moving_average="3.69"
change_from_52_week_high="-5.73"
change_From_52_week_low="19.56"
change_in_percent="-0.03%"
close="32.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.46"
ebitda="-65.10M"
eps_estimate_current_year="-2.74"
eps_estimate_next_quarter="-0.79"
eps_estimate_next_year="-4.07"
ex_dividend_date="N/A"
float_shares="18345000"
high="32.95"
high_52_weeks="38.33"
last_trade_date="1/19/2017"
last_trade_price="32.60"
last_trade_size="16072"
last_trade_time="4:00pm"
low="31.78"
low_52_weeks="13.04"
market_capitalization="889.75M"
moving_average_200_day="27.84"
moving_average_50_day="28.91"
name="Blueprint Medicines Corporation"
notes="N/A"
one_year_target_price="37.33"
open="32.03"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+17.08%"
percent_change_from_50_day_moving_average="+12.75%"
percent_change_from_52_week_high="-14.95%"
percent_change_from_52_week_low="+150.00%"
previous_close="32.61"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.11"
price_per_sales="36.01"
revenue="24.72M"
shares_outstanding="27293000"
short_ratio="5.25"
stock_exchange="NMS"
symbol="BPMC"
volume="271752"
weeks_range_52="13.04 - 38.33"
